EdgarLookup

AIS Holdings Group, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AIS Holdings Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-385.8%
Profit Margin
Net income ÷ revenue
-0.6x
Debt-to-Equity
Total liabilities ÷ equity
-62.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2024 $20.0K Jul 9, 2025
FY2024 Mar 31, 2023 $53.3K Jul 5, 2024
FY2023 Mar 31, 2022 $44.7K Jun 26, 2023
FY2022 Mar 31, 2021 $84.7K Jun 10, 2022
FY2021 Mar 31, 2020 $96.4K Jun 23, 2021
FY2020 Mar 31, 2019 $96.3K Jun 16, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 ($77.2K) Jul 9, 2025
FY2025 Mar 31, 2024 ($51.0K) Jul 9, 2025
FY2024 Mar 31, 2023 ($13.0K) Jul 5, 2024
FY2023 Mar 31, 2022 ($10.4K) Jun 26, 2023
FY2022 Mar 31, 2021 $12.1K Jun 10, 2022
FY2021 Mar 31, 2020 ($43.4K) Jun 23, 2021
FY2020 Mar 31, 2019 ($44.7K) Jun 16, 2020
FY2019 Mar 31, 2018 ($25.4K) Jun 11, 2019
FY2018 Mar 31, 2017 ($5.5K) Jul 3, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 ($55.2K) Jul 9, 2025
FY2025 Mar 31, 2024 ($37.2K) Jul 9, 2025
FY2024 Mar 31, 2023 ($47.6K) Jul 5, 2024
FY2023 Mar 31, 2022 $39.7K Jun 26, 2023
FY2022 Mar 31, 2021 $32.7K Jun 10, 2022
FY2021 Mar 31, 2020 ($24.9K) Jun 23, 2021
FY2020 Mar 31, 2019 ($35.7K) Jun 16, 2020
FY2019 Mar 31, 2018 ($19.1K) Jun 11, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2021 Mar 31, 2021 $98.1K Jun 23, 2021
FY2021 Mar 31, 2020 $149.4K Jun 23, 2021
FY2020 Mar 31, 2019 $114.7K Jun 16, 2020

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 ($163.1K) Jul 9, 2025
FY2025 Mar 31, 2024 ($101.0K) Jul 9, 2025
FY2024 Mar 31, 2023 ($69.6K) Jul 5, 2024
FY2023 Mar 31, 2022 ($67.1K) Jun 26, 2023
FY2021 Mar 31, 2021 ($71.0K) Jun 23, 2021
FY2021 Mar 31, 2020 ($93.9K) Jun 23, 2021
FY2020 Mar 31, 2019 ($58.8K) Jun 16, 2020
FY2019 Mar 31, 2018 ($22.9K) Jun 11, 2019
FY2018 Mar 31, 2017 ($3.4K) Nov 28, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 ($258.4K) Jul 9, 2025
FY2025 Mar 31, 2024 ($181.2K) Jul 9, 2025
FY2024 Mar 31, 2023 ($130.3K) Jul 5, 2024
FY2023 Mar 31, 2022 ($117.3K) Jun 26, 2023
FY2022 Mar 31, 2021 ($106.9K) Jun 10, 2022
FY2021 Mar 31, 2020 ($119.0K) Jun 23, 2021
FY2020 Mar 31, 2019 ($75.6K) Jun 16, 2020
FY2019 Mar 31, 2018 ($30.9K) Jun 11, 2019
FY2018 Mar 31, 2017 ($5.5K) Nov 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $6 Jul 9, 2025
FY2025 Mar 31, 2024 $1.2K Jul 9, 2025
FY2025 Mar 31, 2023 $3.0K Jul 9, 2025
FY2024 Mar 31, 2022 $45.3K Jul 5, 2024
FY2023 Mar 31, 2021 $23.1K Jun 26, 2023
FY2022 Mar 31, 2020 $41.6K Jun 10, 2022
FY2020 Mar 31, 2019 $36.7K Jun 16, 2020
FY2019 Mar 31, 2018 $11.9K Jun 11, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2021 Mar 31, 2021 0 Jun 23, 2021
FY2021 Mar 31, 2020 0 Jun 23, 2021
FY2020 Mar 31, 2019 0 Jun 16, 2020
FY2019 Mar 31, 2018 0 Jun 11, 2019
FY2018 Mar 31, 2017 0 Nov 28, 2018

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2022 Mar 31, 2022 20.00M Jun 10, 2022
FY2021 Mar 31, 2021 20.00M Jun 23, 2021
FY2021 Mar 31, 2020 20.00M Jun 23, 2021
FY2020 Mar 31, 2019 20.00M Jun 16, 2020
FY2019 Mar 31, 2018 20.00M Jun 11, 2019
FY2018 Mar 31, 2017 20.00M Nov 28, 2018